Drug profile · INN
pyrazinamide
PYRAZINAMIDE
pyrazinamide (PYRAZINAMIDE) is a 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — pyrazinamide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 4
- Data quality
- 0.84
Quick answer
pyrazinamide (PYRAZINAMIDE) is a 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
70S ribosome inhibitor
Primary target: 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pyrazinamide?
pyrazinamide (PYRAZINAMIDE) is a 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pyrazinamide?
PYRAZINAMIDE is a marketed brand name for pyrazinamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pyrazinamide?
pyrazinamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.